Prognostic value of B7-H3 expression in metastatic renal cell carcinoma and its impact on immunotherapy response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Prognostic value of B7-H3 expression in metastatic renal cell carcinoma and its impact on immunotherapy response ; volume:24 ; number:1 ; day:29 ; month:11 ; year:2024 ; pages:1-10 ; date:12.2024
BMC cancer ; 24, Heft 1 (29.11.2024), 1-10, 12.2024
- Creator
-
Özalp, Faruk Recep
Yörükoğlu, Kutsal
Yıldırım, Eda Çalışkan
Uzun, Mehmet
Semiz, Hüseyin Salih
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-024-13238-x
- URN
-
urn:nbn:de:101:1-2502142111581.147255089323
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:40 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Özalp, Faruk Recep
- Yörükoğlu, Kutsal
- Yıldırım, Eda Çalışkan
- Uzun, Mehmet
- Semiz, Hüseyin Salih
- SpringerLink (Online service)
Other Objects (12)
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Identification of the receptor B7-H3
Pediatric medulloblastoma express immune checkpoint B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer
B7-H3 is widely expressed in soft tissue sarcomas
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Identification of the receptor B7-H3
Pediatric medulloblastoma express immune checkpoint B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer
B7-H3 is widely expressed in soft tissue sarcomas
Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer
Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
Identification of the receptor B7-H3
Pediatric medulloblastoma express immune checkpoint B7-H3
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
A promising target for breast cancer: B7-H3
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer
B7-H3 is widely expressed in soft tissue sarcomas